The standout achievement of this study lies in the successful induction of virus-specific CD8+ T cells by PepGNP-Dengue, signifying a shift in the paradigm of dengue vaccine development historically focused on the induction of3,4 neutralizing antibodies. The gene discussed is CD8A; the disease is dengue disease.